Search research articles
Contact Us
Filters
Showing results (111-120 of 290) with videos related to
Page
of 29
Sort By:
Journal of Crohn'S & Colitis
|
April 28, 2012
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
Filip Baert, Elien Glorieus, Cathérine Reenaers, et al.
Journal of Crohn'S & Colitis
|
May 19, 2012
Management of inflammatory bowel disease in pregnancy
Séverine Vermeire, Franck Carbonnel, Pierre G Coulie, et al.
Journal of Biomedicine & Biotechnology
|
December 24, 2009
Challenges for biomarker discovery in body fluids using SELDI-TOF-MS
Muriel De Bock, Dominique de Seny, Marie-Alice Meuwis, et al.
Journal of Gastroenterology and Hepatology
|
August 30, 2007
Clinical and genetic factors associated with sacroiliitis in Crohn's disease
Harald Peeters, Bert Vander Cruyssen, Herman Mielants, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 31, 2019
Perspectives From Patients and Gastroenterologists on De-escalating Therapy for Crohn's Disease
Corey A Siegel, Kimberly D Thompson, Danielle Walls, et al.
BMJ Open
|
November 4, 2021
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial
Marleen Bouhuys, Willem S Lexmond, Gerard Dijkstra, et al.
Inflammatory Bowel Diseases
|
April 16, 2013
Serum adalimumab concentration and clinical remission in patients with Crohn's disease
Yi-Lin Chiu, David T Rubin, Severine Vermeire, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients
Gilles Thibault, Gilles Paintaud, Hsueh Cheng Sung, et al.
Advances in Therapy
|
November 18, 2016
Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study
Pierre Michetti, John Weinman, Ulrich Mrowietz, et al.
Inflammatory Bowel Diseases
|
January 9, 2007
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection
Andre Van Gossum, Olivier Dewit, Edouard Louis, et al.
Page
of 29
Search research articles
Search
Showing results (111-120 of 290) with videos related to
Sort By:
Page
of 29
Journal of Crohn'S & Colitis
|
April 28, 2012
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
Filip Baert, Elien Glorieus, Cathérine Reenaers, et al.
Journal of Crohn'S & Colitis
|
May 19, 2012
Management of inflammatory bowel disease in pregnancy
Séverine Vermeire, Franck Carbonnel, Pierre G Coulie, et al.
Journal of Biomedicine & Biotechnology
|
December 24, 2009
Challenges for biomarker discovery in body fluids using SELDI-TOF-MS
Muriel De Bock, Dominique de Seny, Marie-Alice Meuwis, et al.
Journal of Gastroenterology and Hepatology
|
August 30, 2007
Clinical and genetic factors associated with sacroiliitis in Crohn's disease
Harald Peeters, Bert Vander Cruyssen, Herman Mielants, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 31, 2019
Perspectives From Patients and Gastroenterologists on De-escalating Therapy for Crohn's Disease
Corey A Siegel, Kimberly D Thompson, Danielle Walls, et al.
BMJ Open
|
November 4, 2021
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial
Marleen Bouhuys, Willem S Lexmond, Gerard Dijkstra, et al.
Inflammatory Bowel Diseases
|
April 16, 2013
Serum adalimumab concentration and clinical remission in patients with Crohn's disease
Yi-Lin Chiu, David T Rubin, Severine Vermeire, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients
Gilles Thibault, Gilles Paintaud, Hsueh Cheng Sung, et al.
Advances in Therapy
|
November 18, 2016
Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study
Pierre Michetti, John Weinman, Ulrich Mrowietz, et al.
Inflammatory Bowel Diseases
|
January 9, 2007
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection
Andre Van Gossum, Olivier Dewit, Edouard Louis, et al.
Page
of 29